Deep Apple's $52 million funding revolutionizing drug discovery

A portfolio company created and incubated by Apple Tree Partners (ATP) has raised $52 million in series A funding to enable it to rapidly discover novel small molecule therapeutics.

Related Keywords

Brian Shoichet ,John Irwin ,Georgios Skiniotis ,Silva Jardine ,Seth Harrison , ,Deep Apple Therapeutics ,Deep Apple ,Spiros Liras ,Venture Partner ,Paul Da Silva Jardine ,Markets Amp Regulations ,Ingredients ,Contract Manufacturing Amp Logistics ,Atient Centricity ,Delivery Technologies ,Processing Equipment ,Regulations ,Contract Manufacturing ,Contract Sales Amp Marketing ,Drug Delivery ,Formulation ,Small Molecule Drugs ,Drug Discovery ,Drug Development ,Artificial Intelligence ,Research ,